AUTOMATING GENOMIC SCAR ANALYSIS FOR HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD): A SOLUTION FOR CLINICAL RESEARCH LABS
Bionano Genomics
by
2y ago
If Your Time Is Short: Homologous recombination deficiency (HRD) is a cell’s inability to repair DNA strands resulting in an acquired rate of chromosome breaks. HRD scoring is an analytical approach to measuring the cellular  ..read more
Visit website
Autism Awareness Month is winding down in 2022. Our commitment to advance understanding of the genetic causes of autism and improve testing will never end!
Bionano Genomics
by
2y ago
Celebrating acceptance and progress during Autism Awareness Month As April comes to an end, we celebrate Autism Awareness Month.  At Bionano, we’ve felt inspired by the people and companies that have united to raise  ..read more
Visit website
Rare Diseases are Not Rare, and Bionano is Committed to Making a Difference
Bionano Genomics
by
2y ago
THE NUMBERS TELL THE REAL STORY Rare diseases are not rare at all, they affect more than 350 million people globally.  Rare diseases are estimated to impact 1 in 15 people worldwide and according to the National Institutes of  ..read more
Visit website
January 12, 2022 – Oncology research demonstrates how OGM can outperform traditional methods in solid tumor analysis
Bionano Genomics
by
2y ago
On Day 3 of Bionano Genomics 2022 Symposium, world-leading experts discussed the application of optical genome mapping (OGM) in solid tumors. Precision medicine is rapidly becoming the norm in oncology clinical management,  ..read more
Visit website
FINAL SPEAKERS FOR BIONANO GENOMICS 2022 VIRTUAL SYMPOSIUM
Bionano Genomics
by
2y ago
Bionano Genomics is excited to share the exceptional speaker line up for its 2022 Symposium, beginning this Monday, January 10. This year’s four-day event will feature 31 oral presentations from 27 different speakers from  ..read more
Visit website
January 10, 2022 – OGM in Constitutional Cytogenetics Applications Reveals More Genome Variants that Matter with Greater Sensitivity and Better Resolution than Traditional Workflows Which Increases Success Rates and Improves Stratification of Subjects
Bionano Genomics
by
2y ago
Bionano Genomics kicked off its 2022 Symposium today with speakers from around the world sharing their experiences using optical genome mapping (OGM) with the Saphyr® system for genomic analysis of constitutional genetic  ..read more
Visit website
January 11, 2022 – Evaluation of OGM in a variety of hematological malignancies demonstrates high concordance with traditional methods, time and cost advantages, and potential for discovery of novel therapeutic targets
Bionano Genomics
by
2y ago
On Day 2 of Bionano Genomics 2022 Symposium, world-leading experts discussed the application of optical genome mapping (OGM) in hematologic malignancies. Over the past decade, molecular profiling has become key to understanding  ..read more
Visit website
January 13, 2022 – Better Together: OGM + NGS Reveals More Answers to Challenging Genomic Questions in Genetic Diseases and Cancer Research
Bionano Genomics
by
2y ago
Bionano Genomics capped off its 2022 Symposium with presentations demonstrating that the combination of optical genome mapping (OGM) and next-generation sequencing (NGS) can reveal more answers in genetic disease and cancer  ..read more
Visit website
Bionano Genomics 2022 Virtual Symposium
Bionano Genomics
by
2y ago
On January 10, Bionano Genomics kicks off its flagship event – the 2022 Symposium – to showcase the Company’s work to transform how the world sees the genome. More than 25 esteemed speakers from around the world will  ..read more
Visit website
The Future of Optical Genome Mapping and Cytogenetics: Alex Hoischen Weighs In
Bionano Genomics
by
2y ago
After his two peer-reviewed studies were published last week, Dr. Alexander Hoischen, associate Professor of Genomics at Radboud University Medical Center, Netherlands, hopped on the Mendelspod podcast to discuss  ..read more
Visit website

Follow Bionano Genomics on FeedSpot

Continue with Google
Continue with Apple
OR